间充质基质细胞来源外泌体改善糖尿病小鼠周围神经病变
该研究探讨间充质基质细胞(MSC)来源外泌体对糖尿病周围神经病变(DPN)小鼠的治疗作用。20周龄db/db糖尿病小鼠每周尾静脉注射MSC外泌体共8周,结果显示外泌体降低热和机械刺激阈值、提高神经传导速度,并增加表皮内神经纤维密度、髓鞘厚度和轴突直径。机制涉及抑制促炎基因及调控TLR4/NF-κB信号通路。
要点
- MSC外泌体改善DPN小鼠的热和机械痛觉及神经传导速度。
- 外泌体增加表皮内神经纤维密度、髓鞘厚度和轴突直径。
- 外泌体抑制M1巨噬细胞标志和促炎细胞因子,富集靶向TLR4/NF-κB的miRNA。
核心结论
- MSC来源外泌体通过抑制促炎基因减轻DPN小鼠的神经血管功能障碍并促进功能恢复。
研究设计与样本
- 从培养的小鼠MSC培养基中通过超速离心分离外泌体。
- 使用20周龄db/db糖尿病小鼠作为DPN模型,同年龄db/m杂合小鼠为对照。
- MSC外泌体每周经尾静脉给药一次,连续8周。
主要发现
- MSC外泌体治疗显著降低糖尿病小鼠的热和机械刺激阈值并提高神经传导速度。
- 组织病理学显示MSC外泌体显著增加FITC-葡聚糖灌注血管密度、表皮内神经纤维数量、髓鞘厚度和坐骨神经轴突直径。
- Western blot显示MSC外泌体降低M1型巨噬细胞标志物并增加M2型标志物。
- MSC外泌体显著抑制促炎细胞因子。
- 生物信息学分析显示MSC外泌体富含靶向Toll样受体4/NF-κB信号通路的miRNA。
临床怎么用
- MSC外泌体可能作为DPN的潜在无细胞治疗策略,但尚未在人体验证。
局限性
- 研究仅在小鼠模型中进行,样本量未报告,临床转化需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Diabetic peripheral neuropathy (DPN) is one of the major complications of diabetes, which contributes greatly to morbidity and mortality. There is currently no effective treatment for this disease. Exosomes are cell-derived nanovesicles and play an important role in intercellular communications. The present study investigated whether mesenchymal stromal cell (MSC)-derived exosomes improve neurological outcomes of DPN. METHODS: Exosomes were isolated from the medium of cultured mouse MSCs by ultracentrifugation. Diabetic mice (BKS.Cg-m+/+Leprdb/J, db/db) at the age of 20 weeks were used as DPN models. Heterozygous mice (db/m) of the same age were used as the control. MSC-exosomes were administered weekly via the tail vein for 8 weeks. Neurological function was evaluated by testing motor and sensory nerve conduction velocities, and thermal and mechanical sensitivity. Morphometric analysis was performed by myelin sheath staining and immunohistochemistry. Macrophage markers and circulating cytokines were measured by western blot and ELISA. MicroRNA (miRNA) array and bioinformatics analyses were performed to examine the exosomal miRNA profile and miRNA putative target genes involved in DPN. RESULTS: Treatment of DPN with MSC-exosomes markedly decreased the threshold for thermal and mechanical stimuli and increased nerve conduction velocity in diabetic mice. Histopathological analysis showed that MSC-exosomes markedly augmented the density of FITC-dextran perfused blood vessels and increased the number of intraepidermal nerve fibres (IENFs), myelin thickness and axonal diameters of sciatic nerves. Western blot analysis revealed that MSC-exosome treatment decreased and increased M1 and M2 macrophage phenotype markers, respectively. Moreover, MSC-exosomes substantially suppressed proinflammatory cytokines. Bioinformatics analysis revealed that MSC-exosomes contained abundant miRNAs that target the Toll-like receptor (TLR)4/NF-κB signalling pathway. CONCLUSIONS/INTERPRETATION: MSC-derived exosomes alleviate neurovascular dysfunction and improve functional recovery in mice with DPN by suppression of proinflammatory genes.
引用
- Fan B, Li C, Szalad A, et al. Mesenchymal stromal cell-derived exosomes ameliorate peripheral neuropathy in a mouse model of diabetes. Diabetologia. 2019. PMID: 31740984. doi:10.1007/s00125-019-05043-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。